← Open Payments lookup

JOHN DARAMOLA: Open Payments

NPI 1013995810 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$402 in 14 payments from 7 companies in 2025. Trend: 2023 $134 · 2024 $361 · 2025 $402

Food & beverage: $402
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$173
Bayer Healthcare Pharmaceuticals Inc.4$72
E.R. Squibb & Sons, L.L.C.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
ABBVIE INC.2$37
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Novo Nordisk Inc1$17

Products named: BREZTRI, Kerendia, FARXIGA, ELIQUIS, CAPLYTA, VRAYLAR, JARDIANCE, Ozempic.

Industry payments across TX — which companies pay providers there.